Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection
Edward J Carr, Mary Wu, Joshua Gahir, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 7, pp. 781-784
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants
Timothy S. Johnston, Shuk Hang Li, Mark M. Painter, et al.
Immunity (2024) Vol. 57, Iss. 4, pp. 912-925.e4
Open Access | Times Cited: 31
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion
Harriet V Mears, George R. Young, Theo Sanderson, et al.
PLoS Biology (2025) Vol. 23, Iss. 1, pp. e3002982-e3002982
Open Access | Times Cited: 1
Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster
Julien Favresse, Constant Gillot, Mélanie Closset, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Open Access | Times Cited: 7
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign
Marianne Shawe‐Taylor, David Greenwood, Agnieszka Hobbs, et al.
The Lancet (2024) Vol. 403, Iss. 10432, pp. 1133-1136
Open Access | Times Cited: 6
A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection
Jun Liu, Li Wang, Alexandra Kurtesi, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics
Giulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Vaccine (2025) Vol. 54, pp. 126960-126960
Closed Access
Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants
Timothy S. Johnston, Shuk Hang Li, Mark M. Painter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates
Deborah Cromer, Arnold Reynaldi, Ainslie Mitchell, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
A Systematic Examination of Generative Artificial Intelligence (GAI) Usage Guidelines for Scholarly Publishing in Medical Journals
Shuhui Yin, Peiyi Lu, Zhuoran Xu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Randomised controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine
Wen Shi Lee, Jennifer Audsley, Mai-Chi Trieu, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 17
Open Access | Times Cited: 2
SARS-CoV-2 mucosal neutralising immunity after vaccination
Edward J Carr, Giulia Dowgier, David Greenwood, et al.
The Lancet Infectious Diseases (2023) Vol. 24, Iss. 1, pp. e4-e5
Open Access | Times Cited: 7
Diminished neutralizing activity against the XBB1.5 strain in 55.9% of individuals post 6 months COVID-19 mRNA booster vaccination: insights from a pseudovirus assay on 1,353 participants in the Fukushima vaccination community survey, Japan
Tianchen Zhao, Yuta Tani, Chieko Makino‐Okamura, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Navigating the complexities of artificial intelligence in scientific writing: a dual perspective
Gabriel Levin, Sabrina Piedimonte, Behrouz Zand
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 10, pp. 1495-1498
Open Access | Times Cited: 1
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study
Timothy Russell, Hermaleigh Townsley, Joel Hellewell, et al.
The Lancet Infectious Diseases (2024)
Open Access | Times Cited: 1
Antigenic imprinting dominates humoral responses to new variants of SARS-CoV-2 in a hamster model of COVID-19
Joran Degryse, Elke Maas, Ria Lassaunière, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Long-Term Immunity Against SARS-CoV-2 Wild Type and Omicron XBB 1.5 in Indonesian Residents after Vaccination and Infection
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
(2024)
Open Access | Times Cited: 1
Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster
Julien Favresse, Constant Gillot, Mélanie Closset, et al.
Authorea (Authorea) (2023)
Open Access | Times Cited: 3
Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates
Deborah Cromer, Arnold Reynaldi, Ainslie Hie, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1
Giulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Immune responses and reinfection of SARS‐CoV‐2 Omicron variant in patients with lung cancer
Chen Chen, Xiaoyun Zhou, Xiaoxing Gao, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 8, pp. 1409-1421
Closed Access
Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants.
Javier García‐Pérez, Alberto M. Borobia, Mayte Pérez‐Olmeda, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110728-110728
Open Access
Long-Term Immunity against SARS-CoV-2 Wild-Type and Omicron XBB.1.5 in Indonesian Residents after Vaccination and Infection
Karismananda Karismananda, Ammar Abdurrahman Hasyim, Akihiko Sakamoto, et al.
Antibodies (2024) Vol. 13, Iss. 3, pp. 72-72
Open Access
Kinetics of neutralising antibodies against SARS-CoV-2 variants
Piero Poletti
The Lancet Infectious Diseases (2024)
Closed Access
Comment on “Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis”
Amin Sharifan
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Evaluating the Quality of Studies Assessing COVID-19 Vaccine Neutralizing Antibody Immunogenicity
Maeva Katzmarzyk, Robert Naughton, Ioannis Sitaras, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1238-1238
Open Access
Page 1 - Next Page

Scroll to top